@techcrunch.com 6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas
@techcrunch.com 7 years ago
Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis